Anebulo Pharmaceuticals Stock Market Value
| ANEB Stock | USD 1.40 0.06 4.11% |
| Symbol | Anebulo |
Anebulo Pharmaceuticals Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anebulo Pharmaceuticals. If investors know Anebulo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anebulo Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.32) | Return On Assets (0.66) | Return On Equity (1.14) |
The market value of Anebulo Pharmaceuticals is measured differently than its book value, which is the value of Anebulo that is recorded on the company's balance sheet. Investors also form their own opinion of Anebulo Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Anebulo Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anebulo Pharmaceuticals' market value can be influenced by many factors that don't directly affect Anebulo Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Anebulo Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Anebulo Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anebulo Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Anebulo Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Anebulo Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Anebulo Pharmaceuticals.
| 10/26/2024 |
| 11/25/2024 |
If you would invest 0.00 in Anebulo Pharmaceuticals on October 26, 2024 and sell it all today you would earn a total of 0.00 from holding Anebulo Pharmaceuticals or generate 0.0% return on investment in Anebulo Pharmaceuticals over 30 days. Anebulo Pharmaceuticals is related to or competes with Eliem Therapeutics, HCW Biologics, Scpharmaceuticals, Milestone Pharmaceuticals, Seres Therapeutics, and Lumos Pharma. Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatme... More
Anebulo Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Anebulo Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Anebulo Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.02) | |||
| Maximum Drawdown | 76.0 | |||
| Value At Risk | (11.48) | |||
| Potential Upside | 8.85 |
Anebulo Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Anebulo Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Anebulo Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Anebulo Pharmaceuticals historical prices to predict the future Anebulo Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.0058 | |||
| Jensen Alpha | (0.27) | |||
| Total Risk Alpha | (1.47) | |||
| Treynor Ratio | (0.03) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Anebulo Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Anebulo Pharmaceuticals Backtested Returns
Anebulo Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.0225, which signifies that the company had a -0.0225% return per unit of standard deviation over the last 3 months. Anebulo Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Anebulo Pharmaceuticals' mean deviation of 5.2, and Risk Adjusted Performance of 0.0058 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.84, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Anebulo Pharmaceuticals will likely underperform. At this point, Anebulo Pharmaceuticals has a negative expected return of -0.2%. Please make sure to confirm Anebulo Pharmaceuticals' coefficient of variation, treynor ratio, skewness, as well as the relationship between the jensen alpha and value at risk , to decide if Anebulo Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.50 |
Modest predictability
Anebulo Pharmaceuticals has modest predictability. Overlapping area represents the amount of predictability between Anebulo Pharmaceuticals time series from 26th of October 2024 to 10th of November 2024 and 10th of November 2024 to 25th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Anebulo Pharmaceuticals price movement. The serial correlation of 0.5 indicates that about 50.0% of current Anebulo Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.5 | |
| Spearman Rank Test | 0.66 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Anebulo Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Anebulo Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Anebulo Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Anebulo Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Anebulo Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Anebulo Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Anebulo Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Anebulo Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Anebulo Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Anebulo Pharmaceuticals Lagged Returns
When evaluating Anebulo Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Anebulo Pharmaceuticals stock have on its future price. Anebulo Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Anebulo Pharmaceuticals autocorrelation shows the relationship between Anebulo Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Anebulo Pharmaceuticals.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Anebulo Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Anebulo Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Anebulo Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Anebulo Pharmaceuticals Stock:Check out Anebulo Pharmaceuticals Correlation, Anebulo Pharmaceuticals Volatility and Anebulo Pharmaceuticals Alpha and Beta module to complement your research on Anebulo Pharmaceuticals. For information on how to trade Anebulo Stock refer to our How to Trade Anebulo Stock guide.You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Anebulo Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.